2047-9158

Translational Neurodegeneration

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 258 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact258 DOIs
2

Add abstracts to 252 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact252 DOIs
3

Add license metadata to 111 records

License metadata tells indexers and readers how each article may be reused.

Low impact111 DOIs

DOIs for this ISSN

Showing the top 5 of 615 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Neuroinflammation in Parkinson’s disease and its potential a… (10.1186/s40035-015-0042-0)
Abstract ORCID License
216.57 771
2 Protein misfolding in neurodegenerative diseases: implicatio… (10.1186/s40035-017-0077-5)
Abstract ORCID License
209.59 622
3 The endosomal-lysosomal system: from acidification and cargo… (10.1186/s40035-015-0041-1)
Abstract ORCID License
207.48 583
4 Alzheimer’s disease hypothesis and related therapies (10.1186/s40035-018-0107-y)
Abstract ORCID License
204.07 525
5 Current understanding of the molecular mechanisms in Parkins… (10.1186/s40035-017-0099-z)
Abstract ORCID License
200.61 472
6 The dual roles of cytokines in Alzheimer’s disease: update o… (10.1186/s40035-016-0054-4)
Abstract ORCID License
181.37 261
7 Imaging biomarkers in Parkinson’s disease and Parkinsonian s… (10.1186/s40035-017-0076-6)
Abstract ORCID License
173.70 206
8 The role of statins in both cognitive impairment and protect… (10.1186/s40035-018-0110-3)
Abstract ORCID License
173.70 206
9 Meta-analyses on prevalence of selected Parkinson’s nonmotor… (10.1186/2047-9158-4-1)
Abstract ORCID License
166.31 164
10 The development prospection of HDAC inhibitors as a potentia… (10.1186/s40035-017-0089-1)
Abstract ORCID License
162.33 145
11 miRNA expression profiles in cerebrospinal fluid and blood o… (10.1186/s40035-016-0053-5)
Abstract ORCID License
161.88 143
12 The effects of exercise on cognition in Parkinson’s disease:… (10.1186/2047-9158-3-5)
Abstract ORCID License
160.49 137
13 Recent advances in transthyretin amyloidosis therapy (10.1186/2047-9158-3-19)
Abstract ORCID License
156.48 121
14 The role of exosomes in the pathogenesis of Alzheimer’ disea… (10.1186/s40035-017-0072-x)
Abstract ORCID License
153.10 109
15 The study of brain functional connectivity in Parkinson’s di… (10.1186/s40035-016-0066-0)
Abstract ORCID License
152.20 106
16 Role of early life exposure and environment on neurodegenera… (10.1186/2047-9158-3-9)
Abstract ORCID License
151.90 105
17 Hydrogen sulfide, nitric oxide, and neurodegenerative disord… (10.1186/s40035-018-0108-x)
Abstract ORCID License
150.65 101
18 Dysregulation of autophagy and mitochondrial function in Par… (10.1186/s40035-016-0065-1)
Abstract ORCID License
149.67 98
19 The associations between Parkinson’s disease and cancer: the… (10.1186/s40035-015-0043-z)
Abstract ORCID License
147.64 92
20 Modulation of tau phosphorylation by environmental copper (10.1186/2047-9158-3-24)
Abstract ORCID License
145.46 86
21 Transcranial magnetic stimulation to understand pathophysiol… (10.1186/s40035-015-0045-x)
Abstract ORCID License
143.54 81
22 Genotype-phenotype correlations of amyotrophic lateral scler… (10.1186/s40035-016-0050-8)
Abstract ORCID License
143.14 80
23 Effect of low versus high frequency stimulation on freezing… (10.1186/s40035-017-0083-7)
Abstract ORCID License
142.73 79
24 Dual destructive and protective roles of adaptive immunity i… (10.1186/2047-9158-3-25)
Abstract ORCID License
141.06 75
25 The recommendations of Chinese Parkinson’s disease and movem… (10.1186/s40035-016-0059-z)
Abstract ORCID License
134.43 61
26 Meta-analysis of risk factors for Parkinson’s disease dement… (10.1186/s40035-016-0058-0)
Abstract ORCID License
133.90 60
27 Photophobia in neurologic disorders (10.1186/s40035-017-0095-3)
Abstract ORCID License
132.81 58
28 Proteomics of protein post-translational modifications impli… (10.1186/2047-9158-3-23)
Abstract ORCID License
132.26 57
29 The role of amyloid beta clearance in cerebral amyloid angio… (10.1186/s40035-017-0091-7)
Abstract ORCID License
131.69 56
30 Development of stem cell-based therapy for Parkinson’s disea… (10.1186/s40035-015-0039-8)
Abstract ORCID License
131.11 55
31 Beclin-1- mediated autophagy may be involved in the elderly… (10.1186/s40035-016-0070-4)
Abstract ORCID License
129.93 53
32 The interplay of aging, genetics and environmental factors i… (10.1186/s40035-019-0165-9)
Abstract ORCID
128.35 368
33 Aldehyde Dehydrogenase 1 making molecular inroads into the d… (10.1186/2047-9158-3-27)
Abstract ORCID License
127.42 49
34 Cardiovascular risk factors and frontotemporal dementia: a c… (10.1186/2047-9158-3-13)
Abstract ORCID License
126.76 48
35 The association between Parkinson’s disease and melanoma: a… (10.1186/s40035-015-0044-y)
Abstract ORCID License
126.09 47
36 The biomarkers of immune dysregulation and inflammation resp… (10.1186/s40035-016-0063-3)
Abstract ORCID License
125.41 46
37 Translational Neurodegeneration in the era of fast growing i… (10.1186/s40035-021-00276-9)
Abstract References ORCID
125.41 46
38 Rest tremor revisited: Parkinson’s disease and other disorde… (10.1186/s40035-017-0086-4)
Abstract ORCID License
124.71 45
39 Update on deep brain stimulation in Parkinson’s disease (10.1186/s40035-015-0034-0)
Abstract ORCID License
123.99 44
40 Salidroside reduces tau hyperphosphorylation via up-regulati… (10.1186/s40035-016-0068-y)
Abstract ORCID License
122.51 42
41 Prevalence of wearing-off and dyskinesia among the patients… (10.1186/2047-9158-3-26)
Abstract ORCID License
121.74 41
42 Characteristics of language impairment in Parkinson’s diseas… (10.1186/2047-9158-4-2)
Abstract ORCID License
121.74 41
43 Clinical features of Parkinson’s disease with and without ra… (10.1186/s40035-017-0105-5)
Abstract ORCID License
120.96 40
44 Considerations on the role of environmental toxins in idiopa… (10.1186/2047-9158-3-10)
Abstract ORCID License
120.15 39
45 Deep brain stimulation for dystonia (10.1186/2047-9158-3-2)
Abstract ORCID License
120.15 39
46 Utility of susceptibility-weighted imaging in Parkinson’s di… (10.1186/s40035-016-0064-2)
Abstract ORCID License
118.48 37
47 Regulation of Myelination in the Central Nervous System by N… (10.1186/2047-9158-3-4)
Abstract ORCID License
117.62 36
48 The role of gene variants in the pathogenesis of neurodegene… (10.1186/s40035-017-0098-0)
Abstract ORCID License
117.62 36
49 A two-phase study evaluating the relationship between Thimer… (10.1186/2047-9158-2-25)
Abstract ORCID License
116.72 35
50 In silico analysis of regulatory networks underlines the rol… (10.1186/2047-9158-3-17)
Abstract ORCID License
116.72 35